Cargando…

Enhancement of SARS-CoV Infection by Proteases

Detalles Bibliográficos
Autores principales:	Matsuyama, Shutoku, Ujike, Makoto, Ishii, Koji, Fukushi, Shuetsu, Morikawa, Shigeru, Tashiro, Masato, Taguchi, Fumihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123023/ https://www.ncbi.nlm.nih.gov/pubmed/17037538 http://dx.doi.org/10.1007/978-0-387-33012-9_42

Ejemplares similares

Pseudotyped Vesicular Stomatitis Virus for Functional Analysis of Sars Coronavirus Spike Protein
por: Fukushi, Shuetsu, et al.
Publicado: (2006)

The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells
por: Matsuyama, Shutoku, et al.
Publicado: (2020)

Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS
por: Saijo, Masayuki, et al.
Publicado: (2005)

Identification of Ferret ACE2 and its Receptor Function for Sars-Coronavirus
por: Zamoto, Aya, et al.
Publicado: (2006)

Mechanisms of establishment of persistent SARS-CoV-infected cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

Mutation in the cytoplasmic retrieval signal of porcine epidemic diarrhea virus spike (S) protein is responsible for enhanced fusion activity
por: Shirato, Kazuya, et al.
Publicado: (2011)

Characterization of Persistent SARS-CoV Infection in Vero E6 Cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

Regulation of p90RSK phosphorylation by SARS‐CoV infection in Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2004)

Pseudotyped Vesicular Stomatitis Virus for Analysis of Virus Entry Mediated by SARS Coronavirus Spike Proteins
por: Fukushi, Shuetsu, et al.
Publicado: (2007)

JNK and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2005)

Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
por: Ishii, Koji, et al.
Publicado: (2006)

Communication between S1N330 and a Region in S2 of Murine Coronavirus Spike Protein Is Important for Virus Entry into Cells Expressing CEACAM1b Receptor
por: Matsuyama, Shutoku, et al.
Publicado: (2002)

Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents
por: Ikejiri, Masahiro, et al.
Publicado: (2007)

Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
por: Iwata-Yoshikawa, Naoko, et al.
Publicado: (2022)

The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells
por: Tomita, Yuriko, et al.
Publicado: (2021)

Highly Attenuated Vaccinia Virus Dis as a Potential Sars Vaccine
por: Ishii, Koji, et al.
Publicado: (2006)

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
por: Matsuyama, Shutoku, et al.
Publicado: (2020)

Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells
por: Mizutani, Tetsuya, et al.
Publicado: (2004)

Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen
por: Yamaoka, Yutaro, et al.
Publicado: (2016)

Incorporation of Spike and Membrane Glycoproteins into Coronavirus Virions
por: Ujike, Makoto, et al.
Publicado: (2015)

Recent Progress in Torovirus Molecular Biology
por: Ujike, Makoto, et al.
Publicado: (2021)

Tyrosine dephosphorylation of STAT3 in SARS coronavirus‐infected Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2004)

Enhancement of cytotoxicity against Vero E6 cells persistently infected with SARS-CoV by Mycoplasma fermentans
por: Mizutani, T., et al.
Publicado: (2007)

Frequent occurrence of mutations in nsp3 and nsp4 of SARS-CoV-2, presumably caused by the inhaled asthma drug ciclesonide
por: Doi, Akihiro, et al.
Publicado: (2022)

Serological Assays Based on Recombinant Viral Proteins for the Diagnosis of Arenavirus Hemorrhagic Fevers
por: Fukushi, Shuetsu, et al.
Publicado: (2012)

Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus
por: Saijo, Masayuki, et al.
Publicado: (2005)

Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells
por: Yamada, Souichi, et al.
Publicado: (2021)

Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2
por: Kobayashi, Jun, et al.
Publicado: (2023)

Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein
por: Fukuma, Aiko, et al.
Publicado: (2015)

Phylogenetic and antigenic characterization of newly isolated porcine epidemic diarrhea viruses in Japan
por: Islam, Md. Taimur, et al.
Publicado: (2016)

Reduction of Cell Fusion by Deletion in the Hypervariable Region of the Spike Protein of Mouse Hepatitis Virus
por: Tennakoon, Nipuna, et al.
Publicado: (2022)

Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
por: Tani, Hideki, et al.
Publicado: (2021)

Hemagglutination mediated by the spike protein of cell-adapted bovine torovirus
por: Shimabukuro, Kozue, et al.
Publicado: (2013)

Analysis of the Function of the Lymphocytic Choriomeningitis Virus S Segment Untranslated Region on Growth Capacity In Vitro and on Virulence In Vivo
por: Taniguchi, Satoshi, et al.
Publicado: (2020)

Effective inactivation of Nipah virus in serum samples for safe processing in low-containment laboratories
por: Watanabe, Shumpei, et al.
Publicado: (2020)

Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022)

Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally
por: Kawashima, Sho, et al.
Publicado: (2023)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications
por: McElvaney, Oisin F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_khn33ed7r13bpm790qvc847v0d